About Valence Labs
Valence Labs is a Healthcare company based in Montreal (Canada) founded in 2017 by Therence Bois, and was acquired by Recursion in May 2023. Research and productization engine within Recursion that focuses on advancing the frontier of AI in drug discovery. Valence Labs has raised $8.5 million across 3 funding rounds from investors including Recursion Pharmaceuticals, Fundica and Fifty Years. Its website valencelabs.com draws about 20 thousand monthly visits. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its legal entity is VALENCE DISCOVERY INC.
Company details
Valence Labs was established in 2017 in Montreal, Canada, as a research and productization unit within Recursion. Focus is placed on applying artificial intelligence to drug discovery processes. Computational methods are utilized to support advancements in healthcare, while open science initiatives and academic collaborations are encouraged. Operations center on developing tools and models for pharmaceutical innovation in the biotech sector.
- Total Equity Funding$8.5M (USD)
in 3 rounds
- Latest Funding Round$8.5M (USD), Seed
Dec 2021
- InvestorsRecursion Pharmaceuticals
& 7 more
- Acquired byRecursion
(May 2023)
Apps and channels of Valence Labs
its YouTube channel Valence Labs has 11.4K subscribers and 30 videos.
Videos from Valence Labs
The most watched videos on Valence Labs's YouTube channel, Valence Labs (11.4K subscribers). Click a video to play it here.
More on Valence Labs.
Funding Insights of Valence Labs
Valence Labs has successfully raised a total of $8.5M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $8.5 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.5M
- Total Rounds 3
- Last Round Seed — $8.5M
- First Round $100,000
(Jul 2018)
- Investors Count 7
All 3 funding rounds of Valence Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | $8.5M | Seed | – | Fifty Years, Air Street Capital | |
| Jul 2018 | $215,000 | Grant | – | – | |
| Jul 2018 | $100,000 | Grant | – | – |
8 investors in total: 7 institutional and 1 angel.
Investors in Valence Labs
Valence Labs has secured backing from 8 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Recursion Pharmaceuticals, Fundica and Fifty Years.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on multiple sectors | fiftyyears.com | San Francisco, United States | ||
Venture capital firm investing in AI & life science sectors | airstreet.com | St. Peter Port, United Kingdom | ||
Venture capital investments are made in precision medicine companies. | amplitudevc.com | Montreal, Canada | ||
Venture capital firm funding transformative technologies | phoenix-vp.com | San Mateo, United States | ||
AI-powered search engine for business funding opportunities is provided. | 2017 | fundica.com | Montreal, Canada | |
An annual event for startups and investors is hosted. | startupfestival.com | Montreal, Canada | ||
JM Jonathan Milner | British angel investor, founder of Abcam, active in biotech and life sciences. | unknown_91be9cc3c8df4116b | ||
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | recursion.com | New York, United States |
Investor details for Valence Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Valence Labs
1 people are tracked at Valence Labs (1 in leadership).
| Name | Role | Group |
|---|---|---|
Therence Bois | Co-Founder | Leadership |
Complete people profiles for Valence Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Valence Labs
4 dated milestones of Valence Labs across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Valence Labs is founded.
- Funding First funding round of $100K.
- Funding Latest funding round, Seed, of $8.5M.
- Exit Acquired by Recursion.
Web traffic of Valence Labs
The website of Valence Labs (valencelabs.com) receives about 20K visits a month.
- Monthly visits20K
▲ 18.8% vs previous month
Websites whose visitors overlap most with Valence Labs. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| oureducation.in | 100% | 46.1K | #762,926 | View details | |
bidd.group | bidd.group | 98% | – | ||
xtremepape.rs | xtremepape.rs | 72% | #195,980 | – | |
| a-star.edu.sg | 72% | 333.6K | #152,622 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Valence Labs
Complete news archive for Valence Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Valence Labs
Valence Labs was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Valence Labs is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Valence Labs is a funded company, having raised a total of $8.5M across 3 funding rounds to date. The company's 1st funding round was a Grant of $100K, raised on Jul 2018.
Valence Labs was established in 2017 in Montreal, Canada, as a research and productization unit within Recursion. Focus is placed on applying artificial intelligence to drug discovery processes. Computational methods are utilized to support advancements in healthcare, while open science initiatives and academic collaborations are encouraged. Operations center on developing tools and models for pharmaceutical innovation in the biotech sector.
Valence Labs has 8 investors. Key investors include Recursion Pharmaceuticals, Fundica, Fifty Years, Air Street Capital, and Amplitude Ventures.
Valence Labs operates through Valence Discovery Inc..
Yes. Valence Labs was acquired by Recursion in May 2023.